For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $1.07 in the prior trading day, Fate Therapeutics Inc (NASDAQ: FATE) closed at $1.06, down -0.93%. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 0.9 million shares were traded. FATE stock price reached its highest trading level at $1.0984 during the session, while it also had its lowest trading level at $1.04.
Ratios:
Our goal is to gain a better understanding of FATE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.27.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 04 ’25 when TAHL CINDY bought 9,037 shares for $1.06 per share.
Valamehr Bahram bought 14,466 shares of FATE for $15,396 on Aug 04 ’25. On Mar 06 ’25, another insider, Wolchko J Scott, who serves as the Former Officer and Director of the company, bought 113,178 shares for $0.93 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 121510976 and an Enterprise Value of -35581996. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.11 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at -2.668 whereas that against EBITDA is 0.211.
Stock Price History:
The Beta on a monthly basis for FATE is 2.21, which has changed by -0.7529138 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $4.66, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -13.19%, while the 200-Day Moving Average is calculated to be -30.12%.
Shares Statistics:
The stock has traded on average 1.78M shares per day over the past 3-months and 1565600 shares per day over the last 10 days, according to various share statistics. A total of 114.60M shares are outstanding, with a floating share count of 107.09M. Insiders hold about 6.58% of the company’s shares, while institutions hold 82.91% stake in the company. Shares short for FATE as of 1752537600 were 9460646 with a Short Ratio of 5.31, compared to 1749772800 on 9512319. Therefore, it implies a Short% of Shares Outstanding of 9460646 and a Short% of Float of 9.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
